MedPath
TGA Approval

HEXAXIM (477405)

477405

HEXAXIM

Sanofi-Aventis Australia Pty Ltd

February 3, 2025

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

Diphtheria toxoid

hepatitis B surface antigen

Pertussis toxoid

Tetanus toxoid

Pertussis filamentous haemagglutinin

Tetanus protein

Poliovirus

Haemophilus type B polysaccharide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.